Initial Therapeutics, Inc.
11
Laurie Selber Silverstein
12/15/2025
12/17/2025
Yes
v
| CLMSAGNT, JNTADMN |
Assigned to: Bankruptcy Judge Laurie Selber Silverstein Chapter 11 Voluntary Asset |
|
Debtor Initial Therapeutics, Inc.
651 Gateway Blvd, Suite 1600 South San Francisco, CA 94080 SAN MATEO-CA Tax ID / EIN: 85-0692453 |
represented by |
L. Katherine Good
Potter Anderson & Corroon LLP 1313 N. Market Street, 6th Floor Wilmington, DE 19801 302-984-6049 Fax : 302-658-1192 Email: kgood@potteranderson.com Ethan H. Sulik
Potter Anderson & Corroon LLP 1313 N Market Street Wilmington, DE 19801 302-984-6000 Email: esulik@potteranderson.com |
U.S. Trustee U.S. Trustee
Office of the United States Trustee J. Caleb Boggs Federal Building 844 King Street, Suite 2207 Lockbox 35 Wilmington, DE 19801 (302)-573-6491 |
| |
Claims Agent Kurtzman Carson Consultants, LLC dba Verita Global
222 N. Pacific Coast Highway Suite 300 El Segundo, CA 90245 |
| Date Filed | # | Docket Text |
|---|---|---|
| 12/17/2025 | 4 | Order Directing Joint Administration of the Debtors Chapter 11 Cases [An order has been entered in accordance with rule 1015(b) of the Federal Rules of Bankruptcy Procedure and rule 1015-1 of the Local Rules of the United States Bankruptcy Court for the District of Delaware directing joint administration for procedural purposes only of the chapter 11 cases of: Apple Tree Life Sciences, Inc. (4506); ATP Life Science Ventures, L.P. (8224); ATP III GP, Ltd. (6091); Apertor Pharmaceuticals, Inc. (3161); Initial Therapeutics, Inc. (2453); Marlinspike Therapeutics, Inc. (4757); and Red Queen Therapeutics, Inc. (8563). All further pleadings and other papers shall be filed in and all further docket entries shall be made in Case No. 25-12177 (LSS), which should also be consulted for all matters affecting this case]. Signed on 12/17/2025 (CMB) (Entered: 12/17/2025) |
| 12/15/2025 | Judge Laurie Selber Silverstein added to case (SJS) (Entered: 12/15/2025) | |
| 12/15/2025 | 3 | Motion for Joint Administration Filed by ATP III GP, Ltd., ATP Life Science Ventures, L.P., Apertor Pharmaceuticals, Inc., Apple Tree Life Sciences, Inc., Initial Therapeutics, Inc., Marlinspike Therapeutics, Inc., Red Queen Therapeutics, Inc.. (Sulik, Ethan) (Entered: 12/15/2025) |
| 12/15/2025 | 2 | Receipt of filing fee for Voluntary Petition (Chapter 11)( 25-12202) [misc,volp11a] (1738.00). Receipt Number A12491120, amount $1738.00. (U.S. Treasury) (Entered: 12/15/2025) |
| 12/15/2025 | 1 | Chapter 11 Voluntary Petition . Fee Amount $1738. Filed by Initial Therapeutics, Inc.. (Good, L. Katherine) (Entered: 12/15/2025) |